Today: 8 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

U.S. natural gas futures fell about 4% early Wednesday to $3.81/mmBtu after a recent surge on colder forecasts and record LNG export demand. EQT Corp shares slipped 0.5% in extended trading, last quoted at $54.36. Average gas flows to U.S. LNG export plants hit 18.5 bcfd so far in December, topping November’s record, LSEG data showed. Investors are watching winter forecasts and upcoming February earnings reports.
31 December 2025
···
XRP price today: Token holds near $1.87 as U.S. XRP ETF inflows extend streak into year-end

XRP price today: Token holds near $1.87 as U.S. XRP ETF inflows extend streak into year-end

XRP traded near $1.87 early Wednesday, up 0.5%, as U.S. spot XRP ETFs logged a 29th straight session of net inflows, totaling $1.15 billion since launch. Bitcoin and ether also rose, while XRP funds drew money even as bitcoin and ether funds saw outflows in December. The 21Shares XRP ETF registration became effective Dec. 10, SEC filings showed. Traders are watching the $2 resistance level amid thin holiday liquidity.
31 December 2025
·
Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

The Dow closed down 94.87 points, or 0.20%, at 48,367.06 in thin holiday trading Tuesday. Federal Reserve minutes showed policymakers split after a quarter-point rate cut, keeping attention on the 2026 rate outlook. Boeing secured an $8.6 billion Pentagon contract tied to the F-15 Israel Program. U.S. bond markets will close early at 2 p.m. ET Wednesday; stocks are shut Thursday for New Year’s Day.
31 December 2025
·······
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

Scholar Rock shares fell 3.2% to $43.76 Tuesday afternoon, underperforming biotech peers as investors watched for updates on FDA reinspection timing for its lead drug, apitegromab. The company aims to resubmit its biologics license application in 2026 after the Indiana fill-finish site, now owned by Novo Nordisk, completes remediation and is reinspected by year-end 2025.
30 December 2025
·
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL shares dropped 3.3% to $84.95 Tuesday afternoon, extending a two-day slide. An Oregon Health & Science University release highlighted PATHFINDER 2 data and confirmed a first-quarter 2026 FDA submission for Galleri. Investors await management’s Jan. 12 update at the J.P. Morgan Healthcare Conference. The stock is down 7.2% since Friday’s close.
30 December 2025
··
TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

NEW YORK, December 30, 2025, 15:14 ET — Regular session Shares of TIC Solutions, Inc. (TIC) fell about 3.5% to $10.02 in afternoon trading on Tuesday, underperforming a largely steady U.S. equity market. The stock last closed at $10.38. The decline came in holiday-thin trade as investors recalibrated rate expectations after the Federal Reserve’s December-meeting minutes hit the tape. “At the end of the day, solid corporate profits can make up for a lot of sins,” said Ryan Detrick, chief market strategist at Carson Group. Reuters The slide matters for TIC because investors have been focused on execution rather than
30 December 2025
··
Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Travere Therapeutics shares fell 3.8% to $37.39 Tuesday afternoon, outpacing declines in biotech ETFs. SEC filings showed Chief Medical Officer Jula Inrig and Chief Commercial Officer Pieter Heerma sold shares on Dec. 24 under pre-arranged 10b5-1 plans. The moves come weeks before a key FDA decision on Filspari for FSGS, set for Jan. 13, 2026. Trading volume reached about 893,000 shares.
30 December 2025
Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals shares fell 3% to $23.33 in thin afternoon trading Tuesday, extending a two-day slide and leaving the stock about 12% below its June high. Biotech ETFs underperformed the broader market, with the iShares Nasdaq Biotechnology ETF down 1.2%. Investors are awaiting the Federal Reserve’s meeting minutes and Catalyst’s next update in January.
30 December 2025
··
Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Kymera Therapeutics shares fell 3% to $77.94 Tuesday afternoon, underperforming a 1.4% drop in the SPDR S&P Biotech ETF. The decline follows December’s $692 million equity raise and positive Phase 1b data for its STAT6 degrader KT-621. The stock traded about 9% below its recent $86 offering price. Investors are watching for updates on trial progress and cash burn ahead of 2026 milestones.
30 December 2025
··
Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Almonty Industries shares fell 3.9% to $8.90 Tuesday after early gains, trading between $8.90 and $9.39. The drop followed news that CEO Lewis Black met U.S. officials and signed a deal tied to future tungsten supply from the Sangdong mine in South Korea, which is set to start production in early 2026. Almonty recently raised $129.4 million in a U.S. share sale and delivered its first ore to Sangdong’s staging area.
30 December 2025
···
Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Praxis Precision Medicines shares fell 3% to $295.50 Tuesday afternoon, retreating after a 14% surge Monday on FDA Breakthrough Therapy Designation for ulixacaltamide in essential tremor. The company plans to submit a New Drug Application in early 2026. Jefferies and BTIG raised price targets following the FDA news.
30 December 2025
··
Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Caris Life Sciences (CAI) stock is down today as biotech slips

Caris Life Sciences shares fell 1.8% to $27.44 by 2:41 p.m. ET Tuesday, underperforming biotech peers as sector benchmarks declined. The drop followed recent attention on Caris’ Genentech partnership, which includes $25 million upfront and up to $1.1 billion in potential milestones. The S&P 500 and Nasdaq were flat. Investors are watching Caris’ test volumes and revenue guidance.
30 December 2025
1 … 292 293 294 295 296 … 540

Stock Market Today

Applied Digital stock surges 25% to $34.95 — what APLD investors are watching next week

Applied Digital stock surges 25% to $34.95 — what APLD investors are watching next week

8 February 2026
Applied Digital shares surged 25.5% to $34.95 Friday, with 44.7 million shares traded after a volatile session. The move followed renewed interest in AI-linked infrastructure stocks and outpaced gains in peers like Core Scientific and Digital Realty. The company recently reported $126.6 million in quarterly revenue and signed major data center leases with hyperscale clients.
Archer Aviation stock jumps 12% into the weekend as small caps lead — what to watch next

Archer Aviation stock jumps 12% into the weekend as small caps lead — what to watch next

8 February 2026
Archer Aviation shares jumped 12.5% to $7.30 Friday, with 50.5 million shares traded as small-cap stocks rallied and tech lagged. ARK Investment Management disclosed a 5.4% stake in Archer on Feb. 3. The company, which has not posted revenue, remains sensitive to sentiment and funding risks. Traders await U.S. jobs data Feb. 11 and inflation data Feb. 13.
Big Tech’s $630B AI data-center spending surge is squeezing chips, electricians — and investor patience

Big Tech’s $630B AI data-center spending surge is squeezing chips, electricians — and investor patience

8 February 2026
Amazon shares fell 9% Friday after announcing a $200 billion capital spending plan for 2026. Alphabet and Meta also outlined record capex, raising concerns about free cash flow and forcing potential cuts to buybacks or increased borrowing. Investors punished several tech stocks, including Amazon, Alphabet, Meta, ServiceNow, and Salesforce, while Nvidia rose. The surge in AI infrastructure spending is straining supply chains and power capacity.
Go toTop